News

May 8, 2017

CDR-Life Announces Formation of Scientific Advisory Board

Inaugural Members Include Leading Ophthalmic Luminaries from the United States and Europe.

Download Press Release (PDF)

ZURICH, Switzerland, May 8, 2017 – CDR-Life Inc., a biotechnology company focused on advancing therapeutic antibody fragments in the areas of ophthalmology and oncology, today announced the formation of a Scientific Advisory Board (SAB) comprised of academic and industry experts in the field of ophthalmology from both the United States and Europe.

The Scientific Advisory Board will serve as a vital strategic resource to the Company to develop novel treatments for ophthalmic diseases. In addition to guiding CDR-Life’s research and development activities, including clinical trial designs, the SAB will also identify new target indications and will evaluate strategic assets that leverage the management’s expertise in therapeutic antibody fragments.

“We are pleased to welcome this diverse group of ophthalmic experts, representing thought leaders from clinical practice and academia, to our newly formed Scientific Advisory Board,” said Dominik Escher, PhD, executive chairman of CDR-Life. “The expertise that they bring to our executive team and Board will prove invaluable as we refine our clinical plan and work to bring novel therapies to patients in need.”

“We believe our approach to developing novel therapeutic antibody fragments holds significant potential in ophthalmology and oncology where unmet medical needs persist,” said Christian Leisner, PhD, chief executive officer of CDR-Life. “We look forward to leveraging the varied experience of our new Scientific Advisory Board as we pursue the efficient development of our proprietary molecules.”

The Advisory Board members include:

Reza Dana, MD – Director at Harvard Medical School, Department of Ophthalmology, Cornea Center of Excellence

Pravin Dugel, MD – Managing Partner, Retinal Consultants of Arizona (RCA)

Frank G. Holz, MD – Chairman and Professor at the Department of Ophthalmology, University of Bonn

Stephan Michels, MD – Professor at the University of Zurich and Vice Chair at City Hospital Triemli, Zurich, Switzerland

Manfred Zierhut, MD – Professor at University Hospital of Tuebingen, Germany